Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2021-09-08 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于控股股东及其一致行动人部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the company's controlling shareholder and related parties. It details the number of shares pledged, the proportion of total shares, pledge start and end dates, and the purpose of the pledge. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledging activity, which fits the category of Capital/Financing Update (CAP). The document length is short (2280 characters), but it contains substantive information about financing activities (share pledging), not just a notice of report publication or certification. Therefore, the correct classification is CAP with high confidence.
2021-09-08 Chinese
第八届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the third meeting of the eighth board of directors of Huabang Life Health Co., Ltd. It details the meeting date, attendance, and the approval of a proposal regarding the sale of shares in a subsidiary. It references a separate announcement for the share sale details. The document is short (603 characters) and serves as a formal notice of board decisions rather than a full report or detailed financial disclosure. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2021-09-03 Chinese
关于出售北京颖泰嘉和生物科技股份有限公司部分股份的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about the sale of a portion of shares in a subsidiary company, including transaction details, parties involved, pricing basis, payment terms, and impact on the company. It includes financial data of the involved companies and references to board meeting resolutions and audit reports. The document is not a full financial report like an Annual Report or Interim Report, nor is it a simple announcement of a report publication. It is a capital transaction update involving share transfer and strategic investment. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2021-09-03 Chinese
颖泰生物资产评估报告
Regulatory Filings
2021-09-03 Chinese
关于2021年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "专项报告" (special report) on the storage and use of raised funds for the half-year period of 2021. It details the status of funds raised from a 2015 private placement, including amounts raised, usage, changes in investment projects, and compliance with regulatory requirements. The document references regulatory guidelines from the Shenzhen Stock Exchange and the China Securities Regulatory Commission regarding the management and use of raised funds. It includes detailed tables on fund usage, changes in projects, and cash management activities. The document is focused on the management and use of capital raised through equity issuance, not on general financial performance or earnings. It is not an annual or interim report, nor an earnings release or management discussion. It is a specialized report on capital raising and fund usage, which fits the definition of a Capital/Financing Update (CAP). The document length is over 7,000 characters and contains substantive financial data related to fundraising and fund usage, not merely an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2021-08-29 Chinese
西南证券股份有限公司关于华邦生命健康股份有限公司部分募投项目结项并将节余募集资金永久补充流动资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed independent verification opinion from Southwest Securities regarding the completion of certain fundraising investment projects and the permanent supplementation of surplus raised funds into working capital by Huabang Life Health Co., Ltd. It references specific fundraising activities, amounts, project changes, and approvals by the board and shareholders. The document includes audit and verification details related to the use of raised funds, compliance with regulatory requirements, and the conclusion of the sponsor institution. It is not a full annual or interim financial report, nor is it a simple announcement. It is a specialized audit or verification report related to fundraising and use of proceeds, which fits the category of an Audit Report / Information (AR). The document length is 3391 characters, which is sufficient for a detailed report rather than a brief announcement. Therefore, the classification is AR with high confidence. Q3 2021
2021-08-29 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.